1
Vernon G Wong, Frank Kochinke: Biocompatible ocular implants. Oculex Pharmaceuticals, Bertram I Rowland, August 22, 1995: US05443505 (332 worldwide citation)

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drags is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outsi ...


2
Vernon G Wong: Biocompatible ocular implants. Oculex Pharmaceuticals, Flehr Hohbach Test Albritton & Herbert, October 20, 1998: US05824072 (289 worldwide citation)

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outsi ...


3
Vernon G Wong, Frank Kochinke: Biocompatible ocular implants. Oculex Pharmaceuticals, Todd A Lorenz, Flehr Hohbach Test Albritton & Herbert, June 16, 1998: US05766242 (261 worldwide citation)

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outsi ...


4
Wong Vernon G, Kochinke Frank: Biocompatible ocular implants. Oculex Pharmaceuticals, ROWLAND Bertram I, May 26, 1995: WO/1995/013765 (1 worldwide citation)

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outsi ...


5
Wong Vernon G, Kochinke Frank: Biocompatible ocular implants. Oculex Pharm, September 4, 1996: EP0729324-A1

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outsi ...


6
Wong Vernon G, Kochinke Frank: Implants oculaires biocompatibles, Biocompatible ocular implants. Oculex Pharmaceuticals, Allergan, FETHERSTONHAUGH & CO, May 26, 1995: CA2176145

Implants comprising active agents are employed for introduction into a suprachor oidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained f or long periods of time, while ensuring the substantial absence of significant levels out ...


7
Vernon G Wong, Frank Kochinke: Biocompatible ocular implants. Oculex Pharmaceuticals, WU XIAONAN, January 1, 1997: CN94194697

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outsi ...


8